Patents Assigned to Immungenetics AG
  • Method for diagnosing or prediagnosing a beta-amyloidopathy or an alpha-synucleopathy
    Patent number: 9370523
    Abstract: The invention relates to a method for the diagnosis or prediagnosis of a ?-amyloidopathy or an ?-synucleopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter, or for determining the risk of a proband suffering from such an illness, the proband already having accumulated substances transported by the cerebral ABCC1 transporter.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: June 21, 2016
    Assignee: Immungenetics AG
    Inventor: Jens Pahnke
  • 2-(R2-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL) PROPYL]-10H-PHENOTHIAZINE FOR TREATING A BETA-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
    Publication number: 20130184268
    Abstract: The invention relates to 2-(R2-thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine according to general formula I, for treating a ?-amyloidopathy or an ?-synucleinopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter. The invention also relates to a method for the diagnosis or prediagnosis of a ?-amyloidopathy or an ?-synucleopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter, or for determining the risk of a proband suffering from such an illness, the proband already having accumulated substances transported by the cerebral ABCC1 transporter.
    Type: Application
    Filed: August 30, 2011
    Publication date: July 18, 2013
    Applicant: Immungenetics AG
    Inventor: Jens Pahnke